Explore

Trendline Trendline
GeoVax Labs Reports Q2 Net Loss Amidst Advancements in Vaccine Study

GeoVax Labs Reports Q2 Net Loss Amidst Advancements in Vaccine Study

GeoVax Labs Reports Q2 Net Loss Amidst Advancements in Vaccine Study
Trendline Trendline
GeoVax Labs Reports Q2 Loss and Advances Vaccine Study

GeoVax Labs Reports Q2 Loss and Advances Vaccine Study

GeoVax Labs Reports Q2 Loss and Advances Vaccine Study
Trendline Trendline
Tonix Pharmaceuticals to Announce Q2 2026 Financial Results Amid Expanding Treatment Portfolio

Tonix Pharmaceuticals to Announce Q2 2026 Financial Results Amid Expanding Treatment Portfolio

Tonix Pharmaceuticals to Announce Q2 2026 Financial Results Amid Expanding Treatment Portfolio
Trendline Trendline
Galderma Reports Strong Financial Growth in First Half of 2026, Raises Sales Guidance

Galderma Reports Strong Financial Growth in First Half of 2026, Raises Sales Guidance

Galderma Reports Strong Financial Growth in First Half of 2026, Raises Sales Guidance
Trendline Trendline
Galderma Reports Strong Financial Growth in First Half of 2026

Galderma Reports Strong Financial Growth in First Half of 2026

Galderma Reports Strong Financial Growth in First Half of 2026
Trendline Trendline
AstraZeneca Reports Strong H1 2026 Results with Continued Growth Momentum

AstraZeneca Reports Strong H1 2026 Results with Continued Growth Momentum

AstraZeneca Reports Strong H1 2026 Results with Continued Growth Momentum
Trendline Trendline
Diamondback Energy to Announce Quarterly Earnings Amid Strong Sales Performance

Diamondback Energy to Announce Quarterly Earnings Amid Strong Sales Performance

Diamondback Energy to Announce Quarterly Earnings Amid Strong Sales Performance
Trendline Trendline
Kiniksa Pharmaceuticals' IL 1 Franchise Expansion Boosts Earnings Forecast

Kiniksa Pharmaceuticals' IL 1 Franchise Expansion Boosts Earnings Forecast

Kiniksa Pharmaceuticals' IL 1 Franchise Expansion Boosts Earnings Forecast
Trendline Trendline
Galderma Increases 2026 Sales Outlook Amid Strong First-Half Performance

Galderma Increases 2026 Sales Outlook Amid Strong First-Half Performance

Galderma Increases 2026 Sales Outlook Amid Strong First-Half Performance
Trendline Trendline
Repligen Corporation Anticipates Steady Growth in Q2 Earnings Report

Repligen Corporation Anticipates Steady Growth in Q2 Earnings Report

Repligen Corporation Anticipates Steady Growth in Q2 Earnings Report
Trendline Trendline
Summit Therapeutics Reports Financial Results and Progress in Ivonescimab Trials

Summit Therapeutics Reports Financial Results and Progress in Ivonescimab Trials

Summit Therapeutics Reports Financial Results and Progress in Ivonescimab Trials
Trendline Trendline
AtriCure Announces Strong Second Quarter 2026 Financial Results with Increased Revenue and Profitability

AtriCure Announces Strong Second Quarter 2026 Financial Results with Increased Revenue and Profitability

AtriCure Announces Strong Second Quarter 2026 Financial Results with Increased Revenue and Profitability